Icon plc Stock
The price for the Icon plc stock decreased slightly today. Compared to yesterday there is a change of -€1.100 (-0.710%).
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Icon plc.
With a target price of 199 € there is a positive potential of 28.84% for Icon plc compared to the current price of 154.45 €.
Pros and Cons of Icon plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | -0.710% | -8.365% | -2.892% | -27.386% | -0.323% | -25.024% | - |
| Alkermes plc | -0.790% | 5.882% | 1.613% | -8.029% | 6.780% | 3.448% | 44.000% |
| Novocure Ltd | -4.380% | 3.488% | 7.181% | -54.591% | 7.322% | -86.197% | -91.552% |
| Ironwood Pharmaceuticals | 0.000% | -9.794% | 14.379% | -20.455% | 31.579% | -66.072% | -63.351% |
Comments
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for ICLR provided by MarketBeat
News
3 Healthcare Pathbreakers With Long-Term Tailwinds
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals
